Author

Kapil Saharia

Observed names: K. Saharia, KAPIL SAHARIA, Kapil K Saharia, Kapil K. Saharia, Saharia, Kapil, Saharia, Kapil K.

Institution: University of Maryland, Baltimore

Observed institutions: University of North Carolina at Chapel Hill, University of Maryland, Baltimore, National Institutes of Health, University of Maryland Medical Center, University of Washington Medical Center, Institute of Human Virology, National Institute of Allergy and Infectious Diseases, University of Maryland School of Medicine, Vaccine Research Center

ORCID: 0000-0002-5116-0042

Observed ORCID: 0000-0002-5116-0042

OpenAlex ID: A5004218416

SARS-CoV-2 infection and persistence in the human body and brain at autopsy

2022 · Sydney R. Stein, Sabrina C. Ramelli, et al. · Nature · 992

PDF

SARS-CoV-2 infection of the oral cavity and saliva

2021 · Ni Huang, Paola Pérez, et al. · Nature Medicine · 764

PDF

Genetically Modified Porcine-to-Human Cardiac Xenotransplantation

2022 · Bartley P. Griffith, Corbin E. Goerlich, et al. · New England Journal of Medicine · 702

PDF

Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

2020 · Olivia S Kates, Brandy M Haydel, et al. · Clinical Infectious Diseases · 403

PDF

Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report

2023 · Muhammad M Mohiuddin, Avneesh K Singh, et al. · The Lancet · 231

PDF

Cryptococcosis

2021 · Alexis C. Gushiken, Kapil K. Saharia, et al. · Infectious Disease Clinics of North America · 118

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

2017 · John H Beigel, Pablo Tebas, et al. · The Lancet Respiratory Medicine · 113

PDF

Transplantation of a genetically modified porcine heart into a live human

2025 · Bartley P. Griffith, Alison Grazioli, et al. · Nature Medicine · 104

Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus

2014 · Douglas M Herrin, Emily E Coates, et al. · Human Vaccines & Immunotherapeutics · 78

PDF

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

PDF

Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

2023 · Hadil Onallah, Ronen Hazan, et al. · Med · 57

Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study

2022 · Akira A. Shishido, Myint Noe, et al. · BMC Infectious Diseases · 55

PDF

Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events

2020 · Ralph Rogers, Kapil Saharia, et al. · BMC Infectious Diseases · 52

PDF

Infection and clinical xenotransplantation: Guidance from the Infectious Disease Community of Practice of the American Society of Transplantation

2023 · Sapna A. Mehta, Kapil K. Saharia, et al. · American Journal of Transplantation · 50

PDF

T Cell Susceptibility to HIV Influences Outcome of Opportunistic Infections

2013 · Kapil K. Saharia, Richard A. Koup · Cell · 42

PDF

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy

2022 · Djordje Atanackovic, Tim Luetkens, et al. · Blood · 33

PDF

Racial and Ethnic Disparities in Pediatric Tuberculosis in North Carolina

2006 · Jason E. Stout, Kapil K. Saharia, et al. · Archives of Pediatrics and Adolescent Medicine · 28

Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells

2016 · Kapil K. Saharia, Constantinos Petrovas, et al. · PLoS ONE · 27

PDF

Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine

2022 · Kapil K Saharia, Jennifer S Husson, et al. · Clinical & Translational Immunology · 25

PDF

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update

2021 · Katya Prakash, Aditya Chandorkar, et al. · Diagnostics · 25

PDF

Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case

2021 · Kevin M. Vannella, Cihan Oguz, et al. · Frontiers in Immunology · 21

PDF

Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series

2021 · Kapil K. Saharia, Shweta Anjan, et al. · Transplant Infectious Disease · 19

Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults

2025 · Natalia Castillo Almeida, Lalitha Parameswaran, et al. · Vaccines · 18

Extracellular vesicles containing SARS‐CoV‐2 proteins are associated with multi‐organ dysfunction and worse outcomes in patients with severe COVID‐19

2024 · Diego de Miguel‐Perez, Marisol Arroyo‐Hernandez, et al. · Journal of Extracellular Vesicles · 17

PDF

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

PDF

Works count: 82

Citation count: 4,204

H-index: 20

I10-index: 29